We found that amplification was the most prevalent kind of alteration in ACC patients, and, using the GSCA database, we found that NBPF1 expression was shown to be inversely linked with methylation levels in patients with ACC. The gene discussed is NBPF1; the disease is adrenal cortex carcinoma.